VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PHAR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PHARPharming Group N.V.
$14.46$1.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPHARQuarterly Financials

Pharming Group N.V. (PHAR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Pharming Group N.V. (PHAR) quarterly income statement — complete revenue, gross profit & net income history

PHAR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q2'21Q1'21
Sales/Revenue72.71M106.5B97.29M93.22M79.09M92.67M74.85M74.03M55.59M81.22M66.66M54.9M42.54M51.01M55.35M50.15M46.62M45.75M42.58M43.56M
Revenue Growth %-8.07%114821.44%29.98%25.92%42.29%14.1%12.28%34.85%30.66%59.22%20.44%9.47%-8.74%11.5%-17.76%7.01%-34.86%-5.93%-19.87%
Cost of Goods Sold6.67M21.1B7.07M8.97M8.32M12.21M6.82M7.99M8.39M7.12M8.29M5.72M4.08M5.86M2.43M4.03M4.88M4.89M3.99M4.84M
COGS % of Revenue9.17%19.81%7.27%9.62%10.52%13.18%9.11%10.8%15.09%8.76%12.44%10.43%9.58%11.49%4.39%8.03%10.46%10.69%9.38%11.12%
Gross Profit66.04M85.4B90.22M84.25M70.77M80.46M68.03M66.04M47.2M74.1M58.37M49.17M38.47M45.15M52.92M46.12M41.74M40.86M38.59M38.72M
Gross Margin %90.83%80.19%92.73%90.38%89.48%86.82%90.89%89.2%84.91%91.24%87.56%89.57%90.42%88.51%95.61%91.97%89.54%89.31%90.62%88.88%
Gross Profit Growth %-6.68%106041.02%32.61%27.58%49.94%8.58%16.56%34.3%22.71%64.11%10.29%6.63%-7.84%10.51%-19.5%7.8%-34.26%-3.83%-20.04%
Operating Expenses63.52M83.4B74.39M73.4M77.81M73.75M63.92M70.03M63.51M73.03M56.46M43.87M52.13M54.66M45M28.3M38.91M42.22M29.32M32.44M
OpEx % of Revenue87.36%78.31%76.47%78.74%98.38%79.59%85.4%94.6%114.26%89.92%84.69%79.92%122.54%107.15%81.29%56.43%83.48%92.29%68.86%74.46%
Selling, General & Admin37.87M51.3B51.08M51.55M57.06M-38.65M43.98M48.45M45.34M-30.48M36.01M44.89M37.09M39.39M33.06M27.95M24.93M25.89M18.69M22M
SG&A % of Revenue52.09%48.17%52.51%55.3%72.14%-41.7%58.76%65.45%81.56%-37.53%54.02%81.77%87.18%77.22%59.73%55.73%53.47%56.59%43.9%50.49%
Research & Development25.65M32.1B23.38M23.7M21.14M22.31M20.72M21.58M18.52M11.63M20.75M20.91M15.62M10.17M12.6M14.43M14.86M17.03M11.56M10.7M
R&D % of Revenue35.28%30.14%24.04%25.42%26.73%24.07%27.68%29.15%33.32%14.32%31.13%38.1%36.72%19.94%22.76%28.78%31.88%37.23%27.15%24.56%
Other Operating Expenses00-72K-1000K-383K1000K-777K0-345K1000K-304K-1000K-579K1000K-659.24K-1000K-873K-701K-927.74K-259K
Operating Income2.52M2B15.82M10.85M-7.04M6.7M4.11M-4M-16.31M1.07M1.91M5.3M-13.66M-9.5M7.92M17.82M2.83M-1.36M9.27M6.28M
Operating Margin %3.47%1.88%16.26%11.64%-8.91%7.23%5.49%-5.4%-29.35%1.32%2.86%9.65%-32.12%-18.63%14.31%35.54%6.06%-2.98%21.76%14.42%
Operating Income Growth %135.79%29732.94%285.18%371.48%56.82%527.13%115.3%-175.42%-19.39%111.25%-75.92%-70.27%-583.65%-596.8%-92.33%-55.04%-106.19%-37.78%-70.71%
EBITDA5.65M2B18.55M13.55M-4.46M14.4M6.85M-4.29M-10.39M8.62M4.81M8.46M-11.36M-2.99M11.07M19.89M5.01M11.6M10.2M8.35M
EBITDA Margin %7.77%1.88%19.07%14.54%-5.64%15.54%9.15%-5.79%-18.69%10.62%7.22%15.41%-26.7%-5.87%20.01%39.67%10.76%25.36%23.96%19.16%
EBITDA Growth %226.59%13808.26%170.75%415.93%57.06%67.01%42.43%-150.69%8.51%388.12%-56.57%-57.47%-326.46%-125.8%-95%-39.91%-53.62%-38.26%-64.22%
D&A (Non-Cash Add-back)3.13M3.21M2.73M2.7M2.58M7.7M2.74M-293K5.92M7.55M2.9M3.16M2.31M6.51M3.15M2.07M2.19M12.96M936.15K2.06M
EBIT2.52M6.2B20.7M7.08M-6.69M7.93M4.51M1.91M-15.07M-688K1.91M3.56M-13.88M-16.85M20.89M20.91M5.61M4.18M9.27M14.39M
Net Interest Income-2.7M-1.4B-7.46M655K-4.49M-151K-2.17M-1.05M223K-4.54M0-2.46M-2.67M-6.3M-1.19M-4.63M1.85M-1.71M-1.29M6.56M
Interest Income0807.91K485K659K604K1.1M825K920K1.78M000123K-4.92M0-3.28M3.23M008.16M
Interest Expense2.7M1.4B7.95M4K5.1M1.25M3M1.97M1.56M4.54M02.46M2.79M1.38M1.19M1.35M1.38M1.71M1.29M1.6M
Other Income/Expense-7.29M2.8B-3.06M-3.77M-4.74M-26K-2.59M3.06M-312K-3.1M1.4M-1.91M-3.01M-934.84K1.55M1.74M1.41M3.84M-2.96M6.51M
Pretax Income-4.77M4.8B12.76M7.08M-11.79M6.68M1.51M299.72K-16.62M-2.03M3.31M3.39M-16.67M-10.44M9.47M19.56M4.23M1.64M6.3M12.79M
Pretax Margin %-6.56%4.51%13.11%7.59%-14.9%7.21%2.02%0.4%-29.91%-2.5%4.96%6.17%-39.2%-20.46%17.11%39%9.08%3.59%14.8%29.36%
Income Tax460.67K-500M5.21M2.53M3.1M3.82M2.55M1.1M-4.18M1.09M-157K2.07M-4.47M3.22M181.65K3.81M772K-217K1.25M4.27M
Effective Tax Rate %-9.66%-10.42%40.83%35.73%-26.3%57.19%168.3%366.67%25.12%-53.77%-4.75%61.05%26.78%-30.88%1.92%19.51%18.24%-13.2%19.85%33.37%
Net Income-5.23M5.3B7.55M4.69M-14.72M2.86M-1.03M-1.2M-12.45M-3.12M3.46M1.32M-12.21M-13.66M9.29M15.74M3.46M1.86M5.05M8.52M
Net Margin %-7.2%4.98%7.76%5.04%-18.61%3.09%-1.38%-1.62%-22.39%-3.85%5.2%2.4%-28.7%-26.78%16.78%31.39%7.42%4.07%11.86%19.56%
Net Income Growth %64.45%185279.5%829.98%491.53%-18.24%191.55%-129.85%-190.89%-1.97%77.14%-62.7%-91.62%-452.73%-834.17%-211.58%-59.39%-82.41%-54.53%-8.3%
Net Income (Continuing)-5.23M5.3B7.55M4.55M-14.89M2.86M-1.03M-1.22M-12.45M-3.12M3.46M1.32M-12.21M-13.66M9.29M15.74M3.46M2.44M5.05M8.52M
Discontinued Operations00000000000000000000
Minority Interest00001.29M000000000000000
EPS (Diluted)-0.080.070.110.07-0.220.05-0.02-0.01-0.15-0.030.050.02-0.15-0.180.100.180.040.020.060.10
EPS Growth %65.91%45.83%787.5%592.96%-46.67%247.69%-132%-188.75%0%81.94%-50%-91.11%-475%-949.06%-197.52%-60%-84.86%-49.58%4.17%
EPS (Basic)-0.080.080.110.07-0.220.05-0.02-0.01-0.15-0.030.050.02-0.15-0.180.110.180.040.020.060.10
Diluted Shares Outstanding70.14M75.77M66.9M66.9M66.9M68.03M64.63M84.79M83.88M83.88M82.04M65.92M82.04M82.04M86.53M86.53M86.53M87.64M80.13M81.95M
Basic Shares Outstanding70.14M66.28M66.9M66.9M66.9M68.03M64.63M84.79M83.88M83.88M82.04M65.92M82.04M82.04M83.05M86.53M86.53M80.25M80.13M79.76M
Dividend Payout Ratio--------------------